Stock listing
Lang & Schwarz:A41AKJ NextCure, Inc. Aktie
German listing (Lang & Schwarz) of NextCure, Inc. · home listing NASDAQ:NXTC
Follow NextCure, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NXTC
$6.31 USD -0.22 (-3.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NXTC
- Day range
- $6.24 – $6.58 USDOct 30, 2026
- Volume
- 19,106 sharesOct 30, 2026
- Market cap
- $28.88M USDAt the close on Oct 30, 2026 · price × 4.58M shares outstanding
- 52-week range
- $1.55 – $15.74 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.00M USDMedian day 99,100 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NXTC · Home | $6.31 USD | -0.215 (-3.3%) | 19,106 | $6.32 | $6.58 | $6.24 | $6.525 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NXTC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.31 | -0.215 | -3.3% | $6.32 | $6.58 | $6.24 | 19,106 | |
| $6.525 | +0.185 | +2.9% | $6.06 | $6.66 | $5.844 | 58,256 | |
| $6.34 | +0.625 | +10.9% | $5.72 | $6.41 | $5.627 | 64,391 | |
| $5.715 | +0.49 | +9.4% | $5.305 | $5.785 | $4.86 | 142,061 | |
| $5.225 | +0.245 | +4.9% | $4.91 | $5.48 | $4.776 | 25,195 | |
| $4.98 | +0.26 | +5.5% | $4.96 | $5.28 | $4.529 | 48,500 | |
| $4.72 | -0.695 | -12.8% | $5.28 | $5.85 | $4.61 | 71,100 | |
| $5.415 | -0.025 | -0.5% | $5.51 | $6.042 | $5.25 | 71,500 | |
| $5.44 | -0.23 | -4.1% | $5.87 | $6.10 | $5.327 | 82,100 | |
| $5.67 | -0.57 | -9.1% | $6.16 | $6.46 | $5.45 | 67,300 | |
| $6.24 | -0.64 | -9.3% | $6.615 | $6.66 | $6.08 | 39,000 | |
| $6.88 | +0.30 | +4.6% | $6.593 | $7.22 | $6.593 | 72,400 | |
| $6.58 | +0.30 | +4.8% | $6.16 | $6.858 | $6.11 | 51,600 | |
| $6.28 | -0.36 | -5.4% | $6.58 | $6.80 | $6.21 | 54,700 | |
| $6.64 | -0.54 | -7.5% | $7.08 | $7.52 | $6.03 | 130,400 | |
| $7.18 | +0.40 | +5.9% | $6.675 | $7.20 | $6.30 | 85,700 | |
| $6.78 | +0.22 | +3.4% | $6.24 | $6.94 | $6.048 | 82,600 | |
| $6.56 | +0.875 | +15.4% | $5.70 | $6.72 | $5.42 | 109,500 | |
| $5.685 | +0.635 | +12.6% | $5.01 | $5.905 | $5.00 | 122,500 | |
| $5.05 | -0.04 | -0.8% | $5.05 | $5.19 | $4.94 | 14,600 | |
| $5.09 | +0.13 | +2.6% | $5.17 | $5.40 | $4.85 | 63,300 | |
| $4.96 | -0.05 | -1.0% | $4.99 | $5.19 | $4.85 | 46,500 | |
| $5.01 | +0.165 | +3.4% | $5.14 | $5.165 | $4.91 | 34,100 | |
| $4.845 | -0.235 | -4.6% | $5.00 | $5.22 | $4.78 | 55,400 | |
| $5.08 | 0.00 | 0.0% | $5.02 | $5.305 | $5.00 | 63,200 | |
| $5.08 | -0.20 | -3.8% | $5.27 | $5.56 | $5.023 | 71,800 | |
| $5.28 | +0.46 | +9.5% | $4.80 | $5.65 | $4.80 | 226,800 | |
| $4.82 | -0.36 | -6.9% | $5.12 | $5.19 | $4.64 | 225,800 | |
| $5.18 | -0.28 | -5.1% | $5.59 | $5.90 | $4.87 | 156,100 | |
| $5.46 | -0.66 | -10.8% | $6.09 | $6.30 | $5.32 | 125,900 | |
| $6.12 | +0.45 | +7.9% | $5.87 | $6.27 | $5.67 | 103,200 | |
| $5.67 | -0.36 | -6.0% | $6.05 | $6.38 | $5.54 | 106,800 | |
| $6.03 | -0.34 | -5.3% | $6.55 | $6.63 | $5.765 | 106,700 | |
| $6.37 | -0.27 | -4.1% | $6.65 | $6.735 | $6.06 | 157,400 | |
| $6.64 | -0.36 | -5.1% | $6.82 | $7.00 | $6.20 | 90,600 | |
| $7.00 | -0.31 | -4.2% | $7.33 | $7.78 | $6.88 | 115,300 | |
| $7.31 | -0.76 | -9.4% | $7.99 | $8.17 | $7.055 | 55,800 | |
| $8.07 | -0.35 | -4.2% | $8.57 | $8.57 | $7.69 | 42,900 | |
| $8.42 | +0.60 | +7.7% | $7.47 | $8.64 | $7.05 | 95,000 | |
| $7.82 | -0.02 | -0.3% | $7.79 | $8.23 | $7.57 | 60,600 | |
| $7.84 | +0.49 | +6.7% | $7.48 | $8.30 | $7.106 | 161,400 | |
| $7.35 | +0.55 | +8.1% | $6.70 | $7.44 | $6.475 | 112,600 | |
| $6.80 | +0.41 | +6.4% | $6.38 | $6.86 | $6.16 | 112,900 | |
| $6.39 | +0.30 | +4.9% | $6.13 | $6.58 | $6.078 | 54,700 | |
| $6.09 | +0.055 | +0.9% | $5.98 | $6.20 | $5.93 | 60,800 | |
| $6.035 | +0.205 | +3.5% | $5.95 | $6.34 | $5.932 | 73,300 | |
| $5.83 | -0.08 | -1.4% | $5.85 | $6.19 | $5.60 | 91,100 | |
| $5.91 | +0.02 | +0.3% | $5.93 | $6.759 | $5.84 | 160,415 | |
| $5.89 | -0.40 | -6.4% | $6.20 | $6.629 | $5.69 | 121,650 | |
| $6.29 | +0.04 | +0.6% | $6.19 | $6.58 | $6.19 | 37,000 | |
| $6.25 | -0.53 | -7.8% | $6.55 | $6.725 | $6.00 | 86,000 | |
| $6.78 | +0.13 | +2.0% | $6.72 | $7.26 | $6.60 | 157,000 | |
| $6.65 | -1.06 | -13.7% | $7.47 | $7.80 | $6.51 | 257,300 | |
| $7.71 | -0.50 | -6.1% | $8.17 | $8.285 | $7.58 | 184,400 | |
| $8.21 | -0.07 | -0.8% | $8.13 | $8.39 | $7.54 | 261,800 | |
| $8.28 | +0.11 | +1.3% | $8.24 | $8.66 | $7.83 | 285,800 | |
| $8.17 | +1.44 | +21.4% | $6.75 | $8.72 | $6.60 | 493,400 | |
| $6.73 | -0.11 | -1.6% | $6.52 | $6.92 | $6.46 | 181,400 | |
| $6.84 | +1.00 | +17.1% | $6.16 | $7.167 | $5.91 | 1,394,500 | |
| $5.84 | +0.25 | +4.5% | $5.27 | $5.91 | $5.15 | 316,100 | |
| $5.59 | +0.34 | +6.5% | $5.16 | $5.73 | $4.95 | 187,000 | |
| $5.25 | -0.53 | -9.2% | $5.78 | $6.00 | $4.95 | 230,000 | |
| $5.78 | +1.38 | +31.4% | $4.69 | $6.07 | $4.613 | 536,300 | |
| $4.40 | +0.255 | +6.2% | $4.38 | $4.59 | $3.95 | 446,600 | |
| $4.145 | -0.885 | -17.6% | $4.91 | $5.08 | $4.10 | 385,700 | |
| $5.03 | +0.01 | +0.2% | $4.98 | $5.26 | $4.40 | 883,100 |
- Ticker
- Lang & Schwarz:A41AKJ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Aug 6, 2026
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
Latest deck · Aug 10, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 21 slides
Latest news
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $5.84 (+4.5%) on Aug 7, 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
Jul 14, 2026
Closed $6.58 (+201.8%) on Jul 14, 2026
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
Jun 4, 2026
Closed $3.19 (+1.3%) on Jun 4, 2026
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
Jun 1, 2026
Closed $3.38 (-45.5%) on Jun 1, 2026
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Closed $9.76 (-4.1%) on May 8, 2026
NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
May 4, 2026
Closed $8.92 (-4.7%) on May 4, 2026
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
Apr 7, 2026
Closed $11.13 (+0.9%) on Apr 7, 2026
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
Mar 31, 2026
Closed $10.53 (-1.4%) on Apr 1, 2026
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
Mar 5, 2026
Closed $12.76 (+1.3%) on Mar 5, 2026
NextCure Provides Business Update
Jan 23, 2026
Closed $11.92 (-5.8%) on Jan 23, 2026
Decks
Merger or Acquisition (August 2026)
Merger or acquisition · 21 slides · Aug 10, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 20 slides · Aug 4, 2026
Investor Presentation (August 2026)
Investor deck · 16 slides · August 2026
Avere Therapeutics — Merger or Acquisition (July 2026)
Merger or acquisition · 20 slides · July 2026
NextCure, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 78 in all · newest Aug 6, 2026 · oldest 2019
- Decks
- 15 decks · latest Aug 10, 2026
Where NextCure, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NXTC · Home listing | NASDAQ | United States | USD |
| BOATS:NXTC | BOATS | United States | USD |
| Frankfurt:2US0 | Frankfurt | Germany | EUR |
| gettex:2US0 | gettex | Germany | EUR |
| Lang & Schwarz:A41AKJ · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41AKJ | LS Exchange | Germany | EUR |
| Munich:2US0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about NextCure, Inc.